🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 4 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/12/2002 56,31 56,32 55,42 55,72 -1,03% 1,59% 6.034.908
10/12/2002 56,07 56,75 55,63 56,30 +0,43% 1,99% 5.687.810
09/12/2002 54,40 56,97 54,40 56,06 +0,31% 4,72% 7.758.973
06/12/2002 55,73 56,36 55,39 55,89 -1,11% 1,73% 6.739.269
05/12/2002 57,01 57,16 55,82 56,52 +0,66% 2,34% 8.936.820
04/12/2002 55,78 56,49 55,39 56,15 +0,03% 1,97% 8.799.532
03/12/2002 56,36 56,46 52,63 56,13 -1,88% 6,79% 25.408.446
02/12/2002 57,68 57,68 56,49 57,20 +0,91% 2,07% 6.655.010
29/11/2002 57,17 57,24 56,42 56,69 -0,82% 1,44% 3.142.009
27/11/2002 56,49 57,48 56,32 57,16 +2,18% 2,06% 6.379.595
26/11/2002 56,87 57,25 55,55 55,94 -2,80% 2,99% 8.019.191
25/11/2002 56,99 57,71 56,68 57,55 +2,17% 1,81% 8.217.473
22/11/2002 56,25 57,03 56,20 56,33 +0,36% 1,48% 9.071.698
21/11/2002 56,77 56,77 55,44 56,13 +2,33% 2,35% 10.822.591
20/11/2002 54,97 55,55 53,98 54,85 -0,23% 2,86% 8.887.564
19/11/2002 53,97 55,33 53,63 54,97 +1,86% 3,16% 8.078.927
18/11/2002 53,32 54,29 52,91 53,97 +2,15% 2,59% 6.693.157
15/11/2002 51,59 52,85 51,55 52,83 +2,65% 2,53% 8.281.610
14/11/2002 50,39 51,70 49,92 51,47 +2,16% 3,52% 8.597.373
13/11/2002 51,62 52,47 49,43 50,38 -3,68% 5,90% 13.138.986
12/11/2002 52,59 53,04 51,92 52,31 -0,38% 2,14% 6.116.966
11/11/2002 53,34 53,50 52,17 52,51 -1,59% 2,50% 5.238.323
08/11/2002 52,88 53,87 52,67 53,36 +0,90% 2,27% 7.123.570
07/11/2002 52,75 53,42 52,73 52,88 -1,04% 1,30% 7.455.472
06/11/2002 51,73 54,01 51,73 53,44 +3,32% 4,41% 15.335.594
05/11/2002 51,23 51,90 50,57 51,72 +0,97% 2,59% 7.923.299
04/11/2002 51,81 52,58 51,10 51,22 -0,70% 2,85% 7.671.360
01/11/2002 51,05 52,19 50,69 51,58 -0,33% 2,95% 7.383.370
31/10/2002 51,76 52,39 51,24 51,76 +0,00% 2,21% 6.750.692
30/10/2002 51,15 51,99 50,70 51,76 +1,48% 2,54% 5.663.497